Genenta Science S.p.A. Proceeds from Issuance or Sale of Equity
Genenta Science S.p.A. (GNTA) reported Proceeds from Issuance or Sale of Equity of EUR 14.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-04-01
| Period end | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|
| 2025-12-31 | 14.79M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 2.98M EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 270.88K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 270.88K EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | 531.00 EUR 20-F · filed 2026-04-01 |